Evidence map›Paper›PMID 40947509›Full record

ArticleBritish journal of haematology2025

Quality and duration of responses with mogamulizumab in cutaneous T-cell lymphomas: Insights into long-lasting outcomes.

Alessandro Broccoli, Lisa Argnani, Alessandro Pileri, Camilla Mazzoni, Benedetta Sordi, Nicola Pimpinelli, Paolo Fava, Pietro Quaglino, Elsa Pennese, Tommasina Perrone and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of haematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Alessandro BroccoliIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.ORCID https://orcid.org/0000-0001-5633-7313
Lisa ArgnaniIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.
Alessandro PileriDipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy.
Camilla MazzoniIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.
Benedetta SordiDivision of Haematology, Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy.
Nicola PimpinelliDivision of Dermatology, Department of Health Sciences, University of Florence, Florence, Italy.
Paolo FavaDermatologic Clinic, Department of Medical Sciences, University of Turin Medical School, Torino, Italy.
Pietro QuaglinoDermatologic Clinic, Department of Medical Sciences, University of Turin Medical School, Torino, Italy.
Elsa PenneseUOC Ematologia Clinica, Dipartimento Oncologico-Ematologico, PO Santo Spirito, Pescara, Italy.
Tommasina PerroneUOC Ematologia con Trapianto, AOU Policlinico di Bari, Bari, Italy.
Andrea BernardelliHaematology and Bone Marrow Transplant Unit, Department of Medicine, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.
Carlo ViscoHaematology and Bone Marrow Transplant Unit, Department of Medicine, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.ORCID https://orcid.org/0000-0003-2863-0883
Miriam TeoliPorphyrias and Rare Diseases Unit, San Gallicano Dermatogical Institute, IRCCS, Rome, Italy.
Leonardo FlenghiAzienda Ospedaliera di Perugia, Perugia, Italy.
Adalberto IbaticiHaematology and Transplant Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Cesare MassoneDermatology Unit, Galliera Hospital, Genoa, Italy.
Pier Luigi ZinzaniIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.ORCID https://orcid.org/0000-0002-2112-2651

Funding

Ministero della Salute RC-2025-2797392
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

mogamulizumabmycosis fungoidesSézary syndrome

Identifiers

PMID40947509
PMCPMC12710180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.